Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Saavedra PHV"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Cryptococcus neoformans Secretes Small Molecules That Inhibit IL-1 β Inflammasome-Dependent Secretion.
Autorzy:
Bürgel PH; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brazil.; Institute of Microbiology and Infection and School of Biosciences, University of Birmingham, Edgbaston, UK B15 2TT.
Marina CL; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brazil.
Saavedra PHV; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Albuquerque P; Laboratory of Molecular Biology of Pathogenic Fungi, University of Brasilia, Brasilia, Brazil.; Faculty of Ceilândia, University of Brasília, Brazil.
de Oliveira SAM; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brazil.
Veloso Janior PHH; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brazil.
de Castro RA; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brazil.
Heyman HM; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.; Bruker Daltonics Inc., Billerica, MA, USA.
Coelho C; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Medical Research Council Centre for Medical Mycology, College of Medicine and Health, University of Exeter and University of Aberdeen, Aberdeen, UK.
Cordero RJB; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Casadevall A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Nosanchuk JD; Departments of Medicine (Division of Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
Nakayasu ES; Bruker Daltonics Inc., Billerica, MA, USA.
May RC; Institute of Microbiology and Infection and School of Biosciences, University of Birmingham, Edgbaston, UK B15 2TT.
Tavares AH; Faculty of Ceilândia, University of Brasília, Brazil.
Bocca AL; Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Brazil.
Pokaż więcej
Źródło:
Mediators of inflammation [Mediators Inflamm] 2020 Dec 03; Vol. 2020, pp. 3412763. Date of Electronic Publication: 2020 Dec 03 (Print Publication: 2020).
Typ publikacji:
Journal Article
MeSH Terms:
Cryptococcus neoformans/*metabolism
Inflammasomes/*metabolism
Interleukin-1beta/*antagonists & inhibitors
Interleukin-1beta/*metabolism
Polysaccharides/*chemistry
Animals ; Caspase 1/metabolism ; Cryptococcosis ; Culture Media, Conditioned ; Dendritic Cells/metabolism ; Fluorescent Antibody Technique ; Lactic Acid/metabolism ; Macrophages/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Phagocytosis ; Polysaccharides/metabolism ; Virulence Factors/metabolism
Czasopismo naukowe
Tytuł:
Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
Autorzy:
Walle LV
Stowe IB
Šácha P
Lee BL
Demon D
Fossoul A
Van Hauwermeiren F
Saavedra PHV
Šimon P
Šubr V
Kostka L
Stivala CE
Pham VC
Staben ST
Yamazoe S
Konvalinka J
Kayagaki N
Lamkanfi M
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2019 Oct 16; Vol. 17 (10), pp. e3000529. Date of Electronic Publication: 2019 Oct 16 (Print Publication: 2019).
Typ publikacji:
Published Erratum
Tytuł:
MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
Autorzy:
Vande Walle L; Inflammation Research Center, VIB, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Discovery Sciences, Janssen Research & Development, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
Stowe IB; Department of Physiological Chemistry, Genentech, South San Francisco, California, United States of America.
Šácha P; Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Prague, Czech Republic.
Lee BL; Department of Physiological Chemistry, Genentech, South San Francisco, California, United States of America.
Demon D; Inflammation Research Center, VIB, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Fossoul A; Inflammation Research Center, VIB, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Van Hauwermeiren F; Inflammation Research Center, VIB, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Janssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
Saavedra PHV; Inflammation Research Center, VIB, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Šimon P; Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Prague, Czech Republic.
Šubrt V; Institute of Macromolecular Chemistry, Academy of Science of the Czech Republic, Prague, Czech Republic.
Kostka L; Institute of Macromolecular Chemistry, Academy of Science of the Czech Republic, Prague, Czech Republic.
Stivala CE; Department of Discovery Chemistry, Genentech, South San Francisco, California, United States of America.
Pham VC; Department of Discovery Chemistry, Genentech, South San Francisco, California, United States of America.
Staben ST; Department of Discovery Chemistry, Genentech, South San Francisco, California, United States of America.
Yamazoe S; Department of Discovery Chemistry, Genentech, South San Francisco, California, United States of America.
Konvalinka J; Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Prague, Czech Republic.
Kayagaki N; Department of Physiological Chemistry, Genentech, South San Francisco, California, United States of America.
Lamkanfi M; Inflammation Research Center, VIB, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Janssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2019 Sep 16; Vol. 17 (9), pp. e3000354. Date of Electronic Publication: 2019 Sep 16 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cryopyrin-Associated Periodic Syndromes/*genetics
Furans/*pharmacology
Inflammasomes/*antagonists & inhibitors
NLR Family, Pyrin Domain-Containing 3 Protein/*antagonists & inhibitors
Sulfonamides/*pharmacology
Animals ; Cytokines/antagonists & inhibitors ; Disease Models, Animal ; Drug Evaluation, Preclinical ; HEK293 Cells ; Heterocyclic Compounds, 4 or More Rings ; Humans ; Indenes ; Lipopolysaccharides ; Macrophages/drug effects ; Mice ; Mice, Inbred C57BL ; NLR Family, Pyrin Domain-Containing 3 Protein/genetics ; Protein Domains ; Sulfones
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies